TradingKey

关于 Madrigal Pharmaceuticals Inc 公司

MDGL简介



公司代码MDGL

公司名称Madrigal Pharmaceuticals Inc

上市日期Feb 06, 2007

CEOMr. Bill Sibold

员工数量528

证券类型Ordinary Share

年结日Feb 06

公司地址200 Barr Harbor Dr Ste 400

城市WEST CONSHOHOCKEN

上市交易所NASDAQ Global Select Consolidated

国家United States of America

邮编19428-2978

电话14043809263

网址https://www.madrigalpharma.com/

公司代码MDGL

上市日期Feb 06, 2007

CEOMr. Bill Sibold

MDGL公司高管



名称

名称/职务

职务

持股

持股变动

Dr. Rebecca A. Taub, M.D.

Director

442.32K

--

Dr. Paul A. Friedman, M.D.

Director

165.12K

--

Dr. Richard S. Levy, M.D.

Independent Director

11.38K

+6.70%

Dr. David Soergel, M.D.

Executive Vice President, Chief Medical Officer

7.54K

--

Mr. Raymond Cheong, M.D., Ph.D.

Independent Director

2.40K

--

Mr. Kenneth M. (Ken) Bate

Independent Director

1.91K

--

Ms. Shannon Kelley

Executive Vice President, Chief Legal Counsel

--

-100.00%

Mr. James M. Daly

Independent Director

--

Mr. Julian C. Baker

Independent Chairman of the Board

--

Mr. Bill Sibold

President, Chief Executive Officer, Director

--

名称

名称/职务

职务

持股

持股变动

Dr. Rebecca A. Taub, M.D.

Director

442.32K

--

Dr. Paul A. Friedman, M.D.

Director

165.12K

--

Dr. Richard S. Levy, M.D.

Independent Director

11.38K

+6.70%

Dr. David Soergel, M.D.

Executive Vice President, Chief Medical Officer

7.54K

--

Mr. Raymond Cheong, M.D., Ph.D.

Independent Director

2.40K

--

Mr. Kenneth M. (Ken) Bate

Independent Director

1.91K

--

收入明细

暂无数据

暂无数据

业务

地区

暂无数据

股东统计

更新时间: 8月16日周六

持股股东

股东类型

持股股东

占比

Janus Henderson Investors

9.83%

Baker Bros. Advisors LP

9.61%

Paulson & Co. Inc.

9.37%

RTW Investments L.P.

8.94%

Avoro Capital Advisors LLC

8.41%

其他

53.83%

持股股东

占比

Janus Henderson Investors

9.83%

Baker Bros. Advisors LP

9.61%

Paulson & Co. Inc.

9.37%

RTW Investments L.P.

8.94%

Avoro Capital Advisors LLC

8.41%

其他

53.83%

股东类型

持股股东

占比

Investment Advisor/Hedge Fund

43.34%

Investment Advisor

33.35%

Hedge Fund

17.09%

Family Office

9.38%

Individual Investor

4.73%

Corporation

2.94%

Research Firm

2.40%

Sovereign Wealth Fund

0.79%

Pension Fund

0.65%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

637

21.95M

98.48%

-2.20M

2025Q2

650

23.67M

106.20%

-1.56M

2025Q1

668

23.83M

107.57%

-1.54M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Janus Henderson Investors

2.19M

9.83%

-14.10K

-0.64%

Jun 30, 2025

Baker Bros. Advisors LP

2.14M

9.61%

+165.68K

+8.38%

Aug 20, 2025

Paulson & Co. Inc.

2.09M

9.37%

-10.00K

-0.48%

Jun 30, 2025

RTW Investments L.P.

1.99M

8.94%

--

Jun 30, 2025

Avoro Capital Advisors LLC

1.88M

8.41%

-147.22K

-7.28%

Jun 30, 2025

The Vanguard Group, Inc.

1.87M

8.41%

+186.99K

+11.08%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

1.26M

5.63%

-59.53K

-4.53%

Jun 30, 2025

State Street Investment Management (US)

690.72K

3.1%

-67.80K

-8.94%

Jun 30, 2025

SQN, L.L.C.

655.54K

2.94%

--

Apr 01, 2025

UBS Financial Services, Inc.

502.21K

2.25%

+211.75K

+72.90%

Jun 30, 2025

持股ETF



更新时间: 10月6日周一

机构名称

占比

Innovator IBD Breakout Opportunities ETF

3.5%

SPDR S&P Biotech ETF

2.6%

Virtus LifeSci Biotech Products ETF

2.45%

Direxion Daily S&P Biotech Bull 3X Shares

1.58%

Tema Heart & Health ETF

1.5%

Global X Guru Index ETF

1.45%

Goldman Sachs Future Health Care Equity ETF

1.11%

Invesco Nasdaq Biotechnology ETF

0.99%

ProShares Ultra Nasdaq Biotechnology

0.99%

First Trust Innovation Leaders ETF

0.87%

Innovator IBD Breakout Opportunities ETF

占比3.5%

SPDR S&P Biotech ETF

占比2.6%

Virtus LifeSci Biotech Products ETF

占比2.45%

Direxion Daily S&P Biotech Bull 3X Shares

占比1.58%

Tema Heart & Health ETF

占比1.5%

Global X Guru Index ETF

占比1.45%

Goldman Sachs Future Health Care Equity ETF

占比1.11%

Invesco Nasdaq Biotechnology ETF

占比0.99%

ProShares Ultra Nasdaq Biotechnology

占比0.99%

First Trust Innovation Leaders ETF

占比0.87%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据